Eli Lilly Opens New Front Against Weight-Drug Compounders
Recent lawsuits from pharma giant Eli Lilly against competitors in the booming weight-loss drug market signal a change in strategy for a company sharply focused on protecting its money-making products....To view the full article, register now.
Already a subscriber? Click here to view full article